Karen Rabin, MD, PhD

Education

Honors & Awards

• 2021 COG Young Investigators Committee Award for Excellence in Mentoring
• 2021 Power of Professionalism Award, Baylor College of Medicine
• 2012 Fulbright & Jaworski Faculty Education Award for Excellence in Teaching and Evaluation
• 2005-2009 NCI K12 Faculty Fellowship in Pediatric Oncology Clinical Research

Selected Publications

1. Mason EJ, Schraw JM, Woodhouse JP, Gramatges MM, Williams KJ, Chen B, Harrell MB, Taylor OA, Scheurer ME, Lupo PJ, Rabin KR, Yi JS, Huynh V, Mittelman SD, Orgel E, Brown A. Lipidomic profiles associated with treatment related hepatotoxicity in children with acute lymphoblastic leukemia. Support Care Cancer. 2026 Feb 17; 34(3):209. View on PubMed
2. Kore P, Geris JM, Leon-Camarena M, Castellanos MI, Taylor OA, Garcia-Morales V, Brown AL, Sok P, Schraw JM, Huynh V, Ludwig KF, Klesse LJ, Pruitt SL, Hughes AE, Tien K, Heym KM, Griffin T, Erana R, Bernini JC, Gramatges MM, Atkinson EG, Lupo PJ, Scheurer ME, Rabin KR. Interplay between genetic ancestry, self-reported race and ethnicity, and clinical factors in pediatric acute lymphoblastic leukemia: A REDIAL Consortium Report. Cancer Epidemiol Biomarkers Prev. 2026 Feb 16. View on PubMed
3. Chavana AN, Mason EJ, Woodhouse JP, Taylor OA, Gramatges MM, Yi JS, Pruitt S, Bernhardt BM, Ludwig K, Klesse L, Heym K, Griffin T, Roberts M, Erana R, Bernini JC, Zhu H, Lupo PJ, Rabin KR, Scheurer ME, Mittelman SD, Huynh V, Orgel E, Brown AL. Incidence and outcomes of treatment-associated hepatotoxicity during pediatric acute lymphoblastic leukemia induction therapy: a Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium report. Haematologica. 2026 Jan 22. View on PubMed
4. Li Z, Yang W, Wu G, Yoshimura S, Mullighan CG, Rosser TC, Leslie-Clarkson EJ, Rabin KR, Lupo PJ, Teachey DT, Yang JJ. The Genomic Architecture of Human DNA Replication Origins. bioRxiv. 2025 Dec 01. View on PubMed
5. Mason EJ, Crain AM, Scheurer ME, Lupo PJ, Rabin KR, Taylor OA, Roberts M, Woodhouse JP, Chavana A, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Gramatges MM, Yi JS, Pruitt SL, Bernhardt MB, Zhu H, Mittelman SD, Huynh V, Orgel E, Schraw JM, Brown AL. An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy. Blood Adv. 2025 Nov 25; 9(22):5802-5810. View on PubMed
6. Langie J, Chan TF, Yang W, Kang AY, Morimoto L, Stram DO, Mancuso N, Ma X, Metayer C, Lupo PJ, Rabin KR, Scheurer ME, Wiemels JL, Yang JJ, de Smith AJ, Chiang CWK. The impact of Indigenous American-like ancestry on the risk of acute lymphoblastic leukemia in Hispanic/Latino children. HGG Adv. 2026 Jan 15; 7(1):100534. View on PubMed
7. Li Z, Yang W, Wu G, Chang TC, Cheng Z, Devidas M, Shago M, Carroll AJ, Heerema NA, Gastier-Foster JM, Wood BL, Sanclemente L, Raetz EA, Hunger SP, Loh ML, Feingold E, Rosser TC, Allen EG, Sherman SL, Rabin KR, Lupo PJ, Yang JJ. Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome. Nat Commun. 2025 Jul 09; 16(1):6316. View on PubMed
8. Vrana C, Zhang M, Rochette M, Alozie M, Oviedo H, Gonzalez A, Sherman J, Zorman B, Sumazin P, Rabin KR, Junco JJ. Efficacy of NAMPT inhibition in T-cell acute lymphoblastic leukemia. PLoS One. 2025; 20(6):e0324443. View on PubMed
9. Harris RD, Taylor OA, Gramatges MM, Hughes AE, Zobeck M, Pruitt S, Bernhardt MB, Chavana A, Huynh V, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Choi A, Ohno Y, Richard MA, Morrison AC, Chen H, Yu B, Lupo PJ, Rabin KR, Scheurer ME, Brown AL. Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. Oncologist. 2025 Jun 04; 30(6). View on PubMed
10. Feldman ER, Li Y, Cutler DJ, Rosser TC, Wechsler SB, Sanclemente L, Rachubinski AL, Elliott N, Vyas P, Roberts I, Rabin KR, Wagner M, Gelb BD, Espinosa JM, Lupo PJ, de Smith AJ, Sherman SL, Leslie-Clarkson EJ. Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS. Genet Epidemiol. 2025 Jun; 49(4):e70010. View on PubMed
11. Chen W, Chang TC, Rabin KR, Raetz EA, Devidas M, Hunger SP, Ramirez NC, Mullighan CG, Loh ML, Wu G. Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes. JCO Clin Cancer Inform. 2025 May; 9:e2400223. View on PubMed
12. Hsu CJ, Schraw JM, Desrosiers TA, Janitz AE, Kirby RS, Nestoridi E, Nembhard WN, Salemi JL, Shumate C, Tanner JP, Yazdy MM, Scheurer ME, Rabin KR, Lupo PJ. All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome. Leukemia. 2025 Jun; 39(6):1516-1519. View on PubMed
13. Langie J, Chan TF, Yang W, Kang AY, Morimoto L, Stram DO, Mancuso N, Ma X, Metayer C, Lupo PJ, Rabin KR, Scheurer ME, Wiemels JL, Yang JJ, de Smith AJ, Chiang CWK. The impact of Indigenous American-like ancestry on risk of acute lymphoblastic leukemia in Hispanic/Latino children. medRxiv. 2025 Apr 10. View on PubMed
14. Iqbal M, McLennan AL, Mukhamedshin A, Dinh MTP, Liu Q, Junco JJ, Mohan A, Srivaths PR, Rabin KR, Fogarty TP, Gifford SC, Shevkoplyas SS, Lam FW. Ultra-low extracorporeal volume microfluidic leukapheresis is safe and effective in a rat model. Nat Commun. 2025 Feb 24; 16(1):1930. View on PubMed
15. Miller TP, Getz KD, Krause E, Jo YG, Charapala S, Gramatges MM, Rabin K, Scheurer ME, Wilkes JJ, Fisher BT, Aplenc R. Erratum: Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR. JCO Clin Cancer Inform. 2025 Feb; 9:e2500013. View on PubMed
16. Flores-Aguilar L, Hamlett ED, Araya P, Barone E, Bhattacharyya A, Carmona-Iragui M, Chan L, Christian B, Costa ACS, Costanzo F, Del Hoyo Soriano L, Dierssen M, Eichler EE, Fisher E, Galbraith M, Ghosh S, Gimenez S, Guedj F, Guidi S, Iulita MF, Mobley W, Pelleri MC, Potier MC, Rabin KR, Rachubinski A, Rebillat AS, Rubenstein E, Saternos H, Sordo L, Strydom A, Valle-Tamayo N, Waugh KA, Yu E, Zeldich E, Busciglio J, Head E. Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society. Neuromolecular Med. 2025 01 05; 27(1):5. View on PubMed
17. Harris RD, Taylor OA, Gramatges MM, Hughes AE, Zobeck M, Pruitt S, Bernhardt MB, Chavana A, Huynh V, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Choi A, Ohno Y, Richard MA, Morrison AC, Chen H, Yu B, Lupo PJ, Rabin K, Scheurer ME, Brown AL. Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 Jan; 45(1):4-11. View on PubMed
18. Chang TC, Chen W, Qu C, Cheng Z, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML. Reply to: Accurate Determinants of Outcome in ALL. J Clin Oncol. 2025 Mar 10; 43(8):1039-1041. View on PubMed
19. Balestra T, Niswander LM, Bagashev A, Loftus JP, Ross SL, Chen RK, McClellan SM, Junco JJ, Bárcenas López DA, Rabin KR, Fry TJ, Tasian SK. Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 2025 Mar; 39(3):555-567. View on PubMed
20. Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, Alexander S, Carroll AJ, Conway S, Gore L, Kirsch I, Kubaney HR, Li AM, McNeer JL, Militano O, Miller TP, Moyer Y, O'Brien MM, Okada M, Reshmi SC, Shago M, Wagner E, Winick N, Wood BL, Haworth-Wright T, Zaman F, Zugmaier G, Zupanec S, Devidas M, Hunger SP, Teachey DT, Raetz EA, Loh ML. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891. View on PubMed

Go to UCSF Profiles, powered by CTSI